A new antibody-drug conjugate is showing promise in the treatment of a rare, aggressive blood cancer, a major conference has heard.
Pivekimab sunirine – PVEK – has been tested in patients with blastic plasmacytoid dendric cell neoplasm (BPDCN), re...
8 months ago
The NHS in England is set to be among the first health services to adopt a new myeloma treatment, it was announced today.
The National Institute for Health and Care Excellence (NICE) announced its backing for belantamab mafodotin – but also faced...
8 months ago
